# Growth Hormone Deficiency in Adults (GHDA)

> **NCT00519558** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 121 (actual)

## Conditions studied

- Growth Hormone Disorder
- Adult Growth Hormone Deficiency

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00519558
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05-31
- **Primary completion:** 2005-01-24
- **Final completion:** 2005-01-24
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2017-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519558, "Growth Hormone Deficiency in Adults (GHDA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00519558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*